1. Home
  2. SM vs CNTA Comparison

SM vs CNTA Comparison

Compare SM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SM
  • CNTA
  • Stock Information
  • Founded
  • SM 1908
  • CNTA 2020
  • Country
  • SM United States
  • CNTA United Kingdom
  • Employees
  • SM N/A
  • CNTA N/A
  • Industry
  • SM Oil & Gas Production
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SM Energy
  • CNTA Health Care
  • Exchange
  • SM Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • SM 2.3B
  • CNTA 2.2B
  • IPO Year
  • SM 1992
  • CNTA 2021
  • Fundamental
  • Price
  • SM $23.03
  • CNTA $12.30
  • Analyst Decision
  • SM Buy
  • CNTA Strong Buy
  • Analyst Count
  • SM 11
  • CNTA 9
  • Target Price
  • SM $48.50
  • CNTA $25.63
  • AVG Volume (30 Days)
  • SM 3.1M
  • CNTA 1.2M
  • Earning Date
  • SM 05-01-2025
  • CNTA 05-12-2025
  • Dividend Yield
  • SM 3.58%
  • CNTA N/A
  • EPS Growth
  • SM N/A
  • CNTA N/A
  • EPS
  • SM 6.67
  • CNTA N/A
  • Revenue
  • SM $2,574,259,000.00
  • CNTA N/A
  • Revenue This Year
  • SM $36.51
  • CNTA N/A
  • Revenue Next Year
  • SM $0.34
  • CNTA N/A
  • P/E Ratio
  • SM $3.45
  • CNTA N/A
  • Revenue Growth
  • SM 13.46
  • CNTA N/A
  • 52 Week Low
  • SM $19.67
  • CNTA $7.75
  • 52 Week High
  • SM $51.94
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • SM 39.38
  • CNTA 40.90
  • Support Level
  • SM $20.51
  • CNTA $11.50
  • Resistance Level
  • SM $22.66
  • CNTA $12.82
  • Average True Range (ATR)
  • SM 2.13
  • CNTA 1.21
  • MACD
  • SM -0.08
  • CNTA 0.03
  • Stochastic Oscillator
  • SM 30.41
  • CNTA 50.95

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Share on Social Networks: